Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time

• Status: Unknown status
• Trial end date: 2016-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients will be randomized to a placebo or study group who will receive topical lidocaine prior to EGD. Amount of medication used, recovery time, patient/endoscopist satisfaction will then be assessed.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brooke Army Medical Center
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• EGD alone performed by staff gastroenterologist as an outpatient

• Between the age of 18 and 89

• Not requiring anesthesia support or use of medications other than fentanyl and midazolam

Exclusion Criteria:

• Prior history of head and neck surgery

• Known hypersensitivity to local anesthetics, the amide type or any components of the topical lidocaine

• Patients having interventions other than polypectomy performed

• Pregnant or breast feeding females

• Patients with severe liver impairment

• Known hypersensitivity to benzodiazepine or fentanyl